Skip to main content
Log in

Assessment of the Cytokine-Producing Resource of Tumor Biopsy Samples from Patients with Invasive Carcinoma of No Special Type and with Non-Malignant Breast Diseases

  • Published:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

In most cases, breast cancer is a malignant neoplasm associated with infiltration of a tumor with the cells that form its microenvironment and produce various cytokines. The aim of the study was to evaluate the cytokine-producing function of tumor cells and their microenvironment in biopsy samples of patients with invasive breast carcinoma of no special type (IBC-NST; group I) and in patients with benign breast diseases (BBD, group II). Patients of group II were further divided into group IIa, which included patients only with fibroadenoma, and group IIb, which included patients with leaf-shaped fibroadenoma, fibroadenomatosis, fibrocystic mastopathy, intraductal papillomatosis and sclerosing adenosis and fibrocystic mastopathy microcalcifications. Concentrations of IL-2, IL-6, IL-8, IL-10, IL-17, IL-18, IL-1β, IL-1Ra, TNF-α, IFN-γ, G-CSF, GM-CSF, VEGF, and MCP-1 were measured in supernatants of breast biopsy samples. The cytokine-producing activity of tumor biopsy samples and its microenvironment was assessed by the index of the polyclonal activator influence (IPAI) on cytokine production. Comparison of groups I and II, revealed high IPAI values on production of IL-17, IL-18 and TNF-α in BBD patients (group II). Higher IPAI values on production of IL-18, TNF-α, and IL-1β and the ratio of IL1β/IL1Ra were observed in BDD patients with fibroadenoma as compared to IBC-NST patients. No statistically significant differences in the IPAI values were found between groups I and IIb. This suggests the existence of changes in the mammary gland in patients of group IIb similar to those in breast carcinoma (IBC-NST) patients. Comparison of groups IIa and IIb revealed higher IPAI values in group IIa (fibroadenoma) patients on production of IL-1β, as well as the ratio of IL1β/IL1Ra. The results of this study have shown some features of the cytokine-producing resource of breast biopsy samples from patents with IBC-NST and BDD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Fabre, J., Giustiniani, J., Garbar, C., Antonicelli, F., Merrouche, Y., Bensussan, A., Bagot, M., and Al-Dacak, R., Int. J. Mol. Sci., 2016, vol. 17, no. 9, 1433. https://doi.org/10.3390/ijms17091433

    Article  CAS  PubMed Central  Google Scholar 

  2. Joyce, J.A., and Fearon, D.T., Science, 2915, vol. 348, pp. 74−80. https://doi.org/10.1126/science.aaa6204

    Article  CAS  Google Scholar 

  3. Quail, D.F., Bowman, R.L., Akkari, L., Quick, M.L., Schuhmacher, A.J., Huse, J.T., Holland, E.C., Sutton, J.C., and Joyce, J.A., Science, 2016, vol. 352, p. 6288. https://doi.org/10.1126/science.aad3018

    Article  CAS  Google Scholar 

  4. Soria, G., Ofri-Shahak, M., Haas, I., Yaal-Hahoshen, N., Leider-Trejo, L., Leibovich-Rivkin, T., Weitzenfeld, P., Meshel, T., Shabtai, E., Gutman, M., and Ben-Baruch, A., BMC Cancer, 2011, vol. 11, 130. https://doi.org/10.1186/1471-2407-11-130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bowman, R.L. and Joyce, J.A., Immunotherapy, 2014, vol. 6, pp. 663−666. https://doi.org/10.2217/imt.14.48

    Article  CAS  PubMed  Google Scholar 

  6. Castells, X., Domingo, L., Corominas, J.M., Torá-Rocamora, I., Quintana, M.J., Baré, M., Vidal, C., Natal, C., Sánchez, M., Saladié, F., Ferrer, J., Vernet, M., Servitja, S., Rodríguez-Arana, A., Roman, M., Espinàs, J.A., and Sala, M., Breast Cancer Res. Treat., 2015, vol. 1, no. 149, pp. 237−244. https://doi.org/10.1007/s10549-014-3208-z

    Article  Google Scholar 

  7. Posso, M., Corominas, J.M., Serrano, L., Roman, M., Torá-Rocamora, I., Domingo, L., Romero, A., Quintana, M.J., Vernet-Tomas, M., Baré, M., Vidal, C., Sánchez, M., Saladié, F., Natal, C., Ferrer, J., Servitja, S., Sala, M., and Castells, X., Cancer Med., 2017, vol. 6, pp. 1482−1509. https://doi.org/10.1002/cam4.1080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Salamat, F., Niakan, B., Keshtkar, A., Rafiei, E., and Zendehdel, M., Iran. J. Med. Sci., 2018, vol. 43, no. 4, pp. 355−364. https://doi.org/10.1002/cam4.1080

    Article  CAS  Google Scholar 

  9. Zendehdel, M., Niakan, B., Keshtkar, A., Rafiei, E., and Salamat, F., Iran. J. Med. Sci., 2018, vol. 43, no. 1, pp. 1−8. PMCID: PMC5775989.

    PubMed  PubMed Central  Google Scholar 

  10. World Medical Association, JAMA, 2013, vol. 310, pp. 2191–2194.

  11. Autenshlyus, A., Arkhipov, S., Mikhailova, E., Marinkin, I., Arkhipova, V., Mogilnaya, E., Varaksin, N., and Rukavishnikov, M., Int. J. Immunopathol. Pharmacol., 2017, vol. 30, no. 3, pp. 308−314. https://doi.org/10.1177/0394632017720055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Freeman, A.E. and Hoffman, R.M., Proc. Natl. Acad. Sci. USA, 1986, vol. 83, no. 8, pp. 2694−2698. https://doi.org/10.1073/pnas.83.8.2694

    Article  CAS  PubMed  Google Scholar 

  13. Yang, B., Kang, H., Fung, A., Zhao, H., Wang, T., and Ma, D., Mediators Inflamm., 2014, vol. 2014, 623759. https://doi.org/10.1155/2014/623759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lyon, D.E., McCain, N.L., Walter, J., and Schubert, C., Nurs. Res., 2008, vol. 57, pp. 51−58. https://doi.org/10.1097/01.NNR.0000280655.58266.6c

    Article  PubMed  PubMed Central  Google Scholar 

  15. Park, I.H., Yang, H.N., Lee, K.J., Kim, T.S., Lee, E.S., Jung, S.Y., Kwon, Y., and Kong, S.Y., Oncotarget., 2017, vol. 8, no. 20, pp. 32722−32730. https://doi.org/10.18632/oncotarget.16281

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yasuda, K., Nakanishi, K., and Tsutsui, H., Int. J. Mol. Sci., 2019, vol. 20, no. 3, 649. https://doi.org/10.3390/ijms20030649

    Article  CAS  PubMed Central  Google Scholar 

  17. Katanov, C., Lerrer, S., Liubomirski, Y., Leider-Trejo, L., Meshel, T., Bar, J., Feniger-Barish, R., Kamer, I., Soria-Artzi, G., Kahani, H., Banerjee, D., and Ben-Baruch, A., Stem. Cell. Res. Ther., 2015, vol. 6, no. 1, 87. https://doi.org/10.1186/s13287-015-0080-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tulotta, C. and Ottewell, P., Endocrine-Related Cancer, 2018, vol. 25, no. 7, pp. 421−434. https://doi.org/10.1530/ERC-17-0309

    Article  Google Scholar 

  19. Nutter, F., Holen, I., Brown, H.K., Cross, S.S., Evans, C.A., Walker, M., Coleman, R.E., West-brook, J.A., Selby, P.J., Brown, J.E., and Otte-well, P.D., Endocrine-Related Cancer, 2014, vol. 21, pp. 327−341. https://doi.org/10.1530/ERC-13-0158

    Article  CAS  PubMed  Google Scholar 

  20. Degnim, A.C., Nassar, A., Stallings-Mann, M., Keith Anderson, S., Oberg, A.L., Vierkant, R.A., Frank, R.D., Wang, C., Winham, S.J., Frost, M.H., Hartmann, L.C., Visscher, D.W., and Radisky, D.C., Breast Cancer Res. Treat., 2015, vol. 3, no. 152, pp. 687−694. https://doi.org/10.1007/s10549-015-3513-1

    Article  CAS  Google Scholar 

  21. Visscher, D.W., Nassar, A., Degnim, A.C., Frost, M.H., Vierkant, R.A., Frank, R.D., Tarabishy, Y., Radisky, D.C., and Hartmann, L.C., Breast Cancer Res. Treat., 2014, vol. 1, no. 144, pp. 205−212. https://doi.org/10.1007/s10549-014-2862-5

    Article  Google Scholar 

  22. Al-Zhoughbi, W., Huang, J., and Paramasivan, G.S., Semin. Oncol., 2014, vol. 41, no. 2, pp. 281−295. https://doi.org/10.1053/j.seminoncol.2014.02.005

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Autenshlyus.

Ethics declarations

All studies were performed in accordance with the Helsinki Declaration [10]. Each patient was informed about the research, its purpose and methods and each patient gave informed consent to conduct this study and obtain samples of tumor biopsy samples; such consent was signed by the patient and certified by a doctor. The Ethics Committee of the Research Institute of Molecular Biology and Biophysics, a division of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk), gave permission for this study.

The authors declare that they have no conflict of interest.

Additional information

Translated by A. Medvedev

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Autenshlyus, A.I., Studenikina, A.A., Bernado, A.V. et al. Assessment of the Cytokine-Producing Resource of Tumor Biopsy Samples from Patients with Invasive Carcinoma of No Special Type and with Non-Malignant Breast Diseases. Biochem. Moscow Suppl. Ser. B 14, 38–43 (2020). https://doi.org/10.1134/S1990750820010047

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750820010047

Keywords:

Navigation